Crescent Biopharma grants inducement stock options for 52,500 shares at $15.83 each
CBIO•Inducement stock options granted to new employees
Crescent Biopharma set inducement equity awards for two new non-executive employees, granting options covering 52,500 ordinary shares.
The options carry a 10-year term and were struck at $15.83 per share, matching the Nasdaq close on July 22, 2026.
Vesting starts with 25% on the first anniversary of each employee’s start date, then monthly in equal installments thereafter.
